ICU Medical Reports Higher Q3 Revenue and Returns to Profit
Revenue was $560.4 million versus $537.0 million a year earlier. GAAP net income was $26.8 million, or $1.07 per diluted share, compared with a $3.4 million loss, or $(0.14) per share. Adjusted diluted EPS rose to $2.44 from $2.03; ICU Medical reaffirmed 2026 guidance and expects to finish toward the higher end of its prior ranges.
ICU Medical, Inc. announced its financial results for the third quarter ended September 30, 2026, reporting GAAP revenue of $560.4 million, an increase from $537.0 million in the prior-year period. The company achieved a GAAP net income of $26.8 million, or $1.07 per diluted share, compared to a net loss of $3.4 million, or $(0.14) per diluted share, in the third quarter of 2025. Adjusted diluted earnings per share rose to $2.44 from $2.03 in the same period last year.
Additionally, the company reaffirmed its full-year 2026 guidance, noting that it expects to finish the fiscal year toward the higher end of its previously provided ranges.